Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522350 · ClinicalTrials.gov registry record · NA
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03522350 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 18 participants.
The verdict
NCT03522350, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the current EmbryoScope Time-Lapse System being used in IVF which has become standard of care to the new model EmbryoScope to demonstrate that the EmbryoScope+ is as safe and reliable as the EmbryoScope.
Interventions
- DEVICE EmbryoScope
- DEVICE EmbryoScope+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2018-06-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03522350
The ClinicalTrials.gov registry entry for NCT03522350 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EmbryoScope is the first listed.
NCT03522350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03522350 about?
NCT03522350 is a clinical study titled "Randomized Trial Comparing EmbryoScope With EmbryoScope+.". The purpose of the study is to compare the current EmbryoScope Time-Lapse System being used in IVF which has become standard of care to the new model EmbryoScope to demonstrate that the EmbryoScope+ is as safe and reliable as the EmbryoScope.
What is the current status of trial NCT03522350?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2017-09-06. Estimated completion is 2018-06-04.
What interventions are being tested in trial NCT03522350?
The interventions under investigation include: EmbryoScope (DEVICE), EmbryoScope+ (DEVICE).
Who is sponsoring clinical trial NCT03522350?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.